26 related articles for article (PubMed ID: 18270495)
1. Effect of Everolimus versus Bone Marrow-Derived Stem Cells on Glomerular Injury in a Rat Model of Glomerulonephritis: A Preventive, Predictive and Personalized Implication.
Zedan MM; Mansour AK; Bakr AA; Sobh MA; Khodadadi H; Salles EL; Alhashim A; Baban B; Golubnitschaja O; Elmarakby AA
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008770
[TBL] [Abstract][Full Text] [Related]
2. The role of transcriptional factor D-site-binding protein in circadian CCL2 gene expression in anti-Thy1 nephritis.
Lu Y; Mei Y; Chen L; Wu L; Wang X; Zhang Y; Fu B; Chen X; Xie Y; Cai G; Bai X; Li Q; Chen X
Cell Mol Immunol; 2019 Sep; 16(9):735-745. PubMed ID: 29568121
[TBL] [Abstract][Full Text] [Related]
3. Roles of mTOR complexes in the kidney: implications for renal disease and transplantation.
Fantus D; Rogers NM; Grahammer F; Huber TB; Thomson AW
Nat Rev Nephrol; 2016 Oct; 12(10):587-609. PubMed ID: 27477490
[TBL] [Abstract][Full Text] [Related]
4. A new apparatus for standardized rat kidney biopsy.
Schirutschke H; Gladrow L; Norkus C; Parmentier SP; Hohenstein B; Hugo CP
PLoS One; 2014; 9(12):e115368. PubMed ID: 25506931
[TBL] [Abstract][Full Text] [Related]
5. Induction monotherapy with sirolimus has selected beneficial effects on glomerular and tubulointersititial injury in nephrotoxic serum nephritis.
Succar L; Lai-Kwon J; Nikolic-Paterson DJ; Rangan GK
Int J Nephrol Renovasc Dis; 2014; 7():303-13. PubMed ID: 25071375
[TBL] [Abstract][Full Text] [Related]
6. Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy.
Daniel C; Vogelbacher R; Stief A; Grigo C; Hugo C
PLoS One; 2013; 8(12):e83846. PubMed ID: 24376766
[TBL] [Abstract][Full Text] [Related]
7. Rapamycin ameliorates proteinuria and restores nephrin and podocin expression in experimental membranous nephropathy.
Stratakis S; Stylianou K; Petrakis I; Mavroeidi V; Poulidaki R; Petra C; Moisiadis D; Stratigis S; Vardaki E; Nakopoulou L; Daphnis E
Clin Dev Immunol; 2013; 2013():941893. PubMed ID: 24069045
[TBL] [Abstract][Full Text] [Related]
8. Delayed mTOR inhibition with low dose of everolimus reduces TGFβ expression, attenuates proteinuria and renal damage in the renal mass reduction model.
Kurdián M; Herrero-Fresneda I; Lloberas N; Gimenez-Bonafe P; Coria V; Grande MT; Boggia J; Malacrida L; Torras J; Arévalo MA; González-Martínez F; López-Novoa JM; Grinyó J; Noboa O
PLoS One; 2012; 7(3):e32516. PubMed ID: 22427849
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 promotes renal tubular epithelial cell protein synthesis: role of mTOR pathway.
Rehman S; Husain M; Yadav A; Kasinath BS; Malhotra A; Singhal PC
PLoS One; 2012; 7(1):e30071. PubMed ID: 22253885
[TBL] [Abstract][Full Text] [Related]
10. HIV-associated nephropathy: role of mammalian target of rapamycin pathway.
Kumar D; Konkimalla S; Yadav A; Sataranatarajan K; Kasinath BS; Chander PN; Singhal PC
Am J Pathol; 2010 Aug; 177(2):813-21. PubMed ID: 20581056
[TBL] [Abstract][Full Text] [Related]
11. Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.
Torres VE; Boletta A; Chapman A; Gattone V; Pei Y; Qian Q; Wallace DP; Weimbs T; Wüthrich RP
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1312-29. PubMed ID: 20498248
[TBL] [Abstract][Full Text] [Related]
12. The mTOR inhibitor everolimus induces proteinuria and renal deterioration in the remnant kidney model in the rat.
Vogelbacher R; Wittmann S; Braun A; Daniel C; Hugo C
Transplantation; 2007 Dec; 84(11):1492-9. PubMed ID: 18091526
[TBL] [Abstract][Full Text] [Related]
13. Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy.
Keller K; Daniel C; Schöcklmann H; Endlich KH; Kerjaschki D; Johnson RJ; Hugo C
Nephrol Dial Transplant; 2006 Oct; 21(10):2724-35. PubMed ID: 16861242
[TBL] [Abstract][Full Text] [Related]
14. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
Daniel C; Ziswiler R; Frey B; Pfister M; Marti HP
Exp Nephrol; 2000; 8(1):52-62. PubMed ID: 10644883
[TBL] [Abstract][Full Text] [Related]
15. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
Krämer S; Wang-Rosenke Y; Scholl V; Binder E; Loof T; Khadzhynov D; Kawachi H; Shimizu F; Diekmann F; Budde K; Neumayer HH; Peters H
Am J Physiol Renal Physiol; 2008 Feb; 294(2):F440-9. PubMed ID: 18094032
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of everolimus-induced glomerulosclerosis after glomerular injury in the rat.
Daniel C; Renders L; Amann K; Schulze-Lohoff E; Hauser IA; Hugo C
Am J Transplant; 2005 Dec; 5(12):2849-61. PubMed ID: 16302997
[TBL] [Abstract][Full Text] [Related]
17. The mTOR inhibitor everolimus attenuates the time course of chronic anti-Thy1 nephritis in the rat.
Wittmann S; Daniel C; Braun A; Vogelbacher R; Shimizu F; Kawachi H; Hugo C
Nephron Exp Nephrol; 2008; 108(2):e45-56. PubMed ID: 18270495
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
